The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.

The new EnzySystem device for hemophilia A could make home clotting tests easier, but patients and caregivers say its ...

Manifold Health AI was created after identifying a fundamental limitation in the at-home diagnostics market: while self-administered blood collection technology is now exceptional, devices alone do ...

The biotechnology company introduces its blood-based testing solution for Alzheimer's disease research, offering researchers an advanced tool to detect multiple biomarkers simultaneously through the ...

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) ...

The Global Alzheimer's Platform Foundation(R) (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...

Keeping pets healthy while avoiding unnecessary medical procedures is a priority for today’s pet owners. VacciCheck ®, an in-clinic immunity test developed by Biogal Galed Laboratories, is helping ...

A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses lately. The San Francisco, CA-based ...